FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:928-931 September 25, 1997 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

There are about 14,000 new cases of thyroid carcinoma in the United States each year, about 90 percent of them differentiated — papillary and follicular — carcinomas, and about 1100 deaths.¹ Thus, the number of patients needing follow-up grows, and because the median age at diagnosis is about 40 years and recurrences can occur at any time for several decades, the follow-up will necessarily be long. Furthermore, a recent study from the National Cancer Institute suggests that the number of cases may increase slightly as a result of the ingestion of radioactive iodine produced by atomic-weapons testing in the western . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Verkooijen, R. B T, Verburg, F. A, van Isselt, J. W, Lips, C. J M, Smit, J. W, Stokkel, M. P M (2008). The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies. Eur J Endocrinol 159: 301-307 [Abstract] [Full Text]  
• Hay, I. D., McDougall, I. R., Sisson, J. C. (2008). Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma. JNM 49: 1395-1397 [Abstract] [Full Text]  
• Cohen, A., Rovelli, A., Merlo, D. F., van Lint, M. T., Lanino, E., Bresters, D., Ceppi, M., Bocchini, V., Tichelli, A., Socie, G. (2007). Risk for Secondary Thyroid Carcinoma After Hematopoietic Stem-Cell Transplantation: An EBMT Late Effects Working Party Study. JCO 25: 2449-2454 [Abstract] [Full Text]  
• Tfelt-Hansen, J., Kanuparthi, D., Chattopadhyay, N. (2006). The emerging role of pituitary tumor transforming gene in tumorigenesis.. Clin Med Res 4: 130-137 [Abstract] [Full Text]  
• Bal, C. S., Kumar, A., Pant, G. S. (2004). Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients. J. Clin. Endocrinol. Metab. 89: 1666-1673 [Abstract] [Full Text]  
• Boelaert, K., McCabe, C. J., Tannahill, L. A., Gittoes, N. J. L., Holder, R. L., Watkinson, J. C., Bradwell, A. R., Sheppard, M. C., Franklyn, J. A. (2003). Pituitary Tumor Transforming Gene and Fibroblast Growth Factor-2 Expression: Potential Prognostic Indicators in Differentiated Thyroid Cancer. J. Clin. Endocrinol. Metab. 88: 2341-2347 [Abstract] [Full Text]  
• Bajen, M T., Mane, S., Munoz, A., Ramon Garcia, J. (2000). Effect of a Diagnostic Dose of 185 MBq 131I on Postsurgical Thyroid Remnants. JNM 41: 2038-2042 [Abstract] [Full Text]  
• Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., Davies, T. F., DeGroot, L. J., Mazzaferri, E. L., Daniels, G. H., Ross, D. S., Luster, M., Samuels, M. H., Becker, D. V., Maxon, H. R. III, Cavalieri, R. R., Spencer, C. A., McEllin, K., Weintraub, B. D., Ridgway, E. C. (1999). A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer. J. Clin. Endocrinol. Metab. 84: 3877-3885 [Abstract] [Full Text]